BROXOMED TOTAL MONTELUKAST 10mg. IP + LEVOCITRIZINE 5mg. IP + AMBROXOL 75mg. IP

Broxomed Total tablets are used for allergic rhinitis symptoms like sneezing and runny nose with thick mucus and cough. Main uses: relief of seasonal allergic rhinitis symptoms such as sneezing, runny nose and itching of the nose and eyes; relief of perennial allergic rhinitis symptoms such as nasal congestion, sneezing and watery discharge; relief of watery, itchy eyes and itching of the nose and throat seen with allergy; loosening and clearing of thick, sticky mucus in the air passages; relief of productive cough associated with thick mucus.

Common side effects of Broxomed Total Tablet include headache; drowsiness or sleepiness; dry mouth; dizziness; tiredness or weakness; nausea or stomach discomfort. Get medical help at once if you notice agitation, aggression, depression, disturbed sleep or other mood and behaviour changes; thoughts of self-harm or suicidal thoughts; severe allergic reactions such as swelling of the face, lips or tongue, or widespread rash.

Each Broxomed Total tablet contains Montelukast 10 mg + Levocitrizine 5 mg + Ambroxol 75 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Broxomed Total Tablet only as your doctor advises.

The MRP of Broxomed Total Tablet is ₹169 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹128.76 and the PTS is ₹115.89.

Each Broxomed Total tablet contains Montelukast 10 mg + Levocitrizine 5 mg + Ambroxol 75 mg. It comes in a pack of 10x10 (Alu Alu).

In this tablet, Montelukast works by blocking leukotrienes, substances that cause allergic swelling, extra mucus and tightening in the nose and air passages. Levocitrizine blocks histamine and so eases sneezing, itching, watery eyes and a runny nose. Ambroxol acts on the mucus itself; it thins thick, sticky phlegm and helps it travel upwards from the air passages, so it is easier to cough out. Together the three ingredients act on allergy, nasal symptoms and mucus at the same time.

Must not be used by anyone allergic to montelukast, levocitrizine, ambroxol or any other ingredient of the tablet. Must not be used in end-stage kidney disease, including in patients on haemodialysis, as levocitrizine is removed from the body by the kidneys. Must not be used to treat a sudden or acute asthma attack; a suitable rescue medicine must be kept ready as advised by the doctor. Check with a doctor first if you have kidney disease of any other stage, as the doctor may need to change the dose or the interval. Check with a doctor first if you have liver disease.

Broxomed Total Tablet is a brand of Vibcare Pharma, sold through its Evermed division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.